RecruitingNCT03050762

Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease


Sponsor

M.D. Anderson Cancer Center

Enrollment

15,000 participants

Start Date

Oct 5, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.


Eligibility

Inclusion Criteria2

  • All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic.
  • In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease.

Exclusion Criteria1

  • N/A

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData Collection

Participant information collected from either source document or direct participant response.

BEHAVIORALFollow Up

Participants followed up at the return to clinic visits. If participant cannot come to clinic, either a questionnaire mailed requesting follow-up, or participant called. Participants followed for a length of 15 years at intervals of every 2-3 years.


Locations(1)

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03050762


Related Trials